Systemic fungemia and hepatic localization of Fusarium Solani in a liver transplanted patient: An emerging fungal agent

Liver Transplantation

Volumn 12, Issue 11, 2006, Pages 1711-1714

  Lodato, Francesca ^a   Tamé, Maria Rosa ^a   Montagnani, Marco ^a   Sambri, Vittorio ^a   Liguori, Giovanna ^a   Azzaroli, Francesco ^a   Costigliola, Paolo ^a   Grazi, Gianluca ^a   Roda, Enrico ^a   Mazzella, Giuseppe ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; ANTICOAGULANT AGENT; CALCINEURIN INHIBITOR; CYCLOSPORIN; FLUCONAZOLE; PIPERACILLIN PLUS TAZOBACTAM; PREDNISONE; STEROID; TEICOPLANIN; TSUKUBAENOLIDE;

ADULT; ARTERY THROMBOSIS; ARTICLE; BLOOD CULTURE; CASE REPORT; FUNGEMIA; FUSARIUM SOLANI; HEPATIC ARTERY; HEPATITIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER ABSCESS; LIVER GRAFT; LIVER GRAFT REJECTION; LIVER ISCHEMIA; LIVER TRANSPLANTATION; MALE; MYCOSIS; NEPHROTOXICITY; OPPORTUNISTIC INFECTION; PLANT PATHOGEN INTERACTION; PRIORITY JOURNAL; SOIL MICROFLORA; SYSTEMIC DISEASE;

ADULT; AMPHOTERICIN B; ANTIFUNGAL AGENTS; FUNGEMIA; FUSARIUM; HUMANS; LIVER; LIVER TRANSPLANTATION; MALE;

EID: 33750968489     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.20899     Document Type: Article

References (31)

1. Denning DW, Evans EG, Kibbler CC, Richardson MD, Roberts MM, Rogers TR, et al. Guidelines for the investigation of invasive fungal infections in hematological malignancy and solid organ transplantation (SOT). British Society for Medical Mycology. Eur J Clin Microbiol Infect Dis 1997; 16:424-436.
2. Guarro J, Gene J. Opportunistic fusarial infections in humans. Eur J Clin Microbiol Infect Dis 1995; 14:741-754.
3. Boutati EI, Anaissie EJ. Fusarium, a significant emerging pathogen in patients with hematologic malignancy: ten years experience at a cancer centre and implications for management. Blood 1997:90:999-1008.
4. La Barba G, Vivarelli M, Golfieri R, Tame MR, Caputo M, Piscaglia F, et al. Hepatic artery thrombosis and graft ischemia in the presence of arterial inflow: not a contradiction but real possibility. Liver Transpl 2004;10:710-711.
5. Morrison VA, Haake RJ, Weisdorf DJ. The spectrum of non-Candida fungal infection following bone marrow transplantation. Medicine (Baltimore) 1993;72:78-89.
6. Singh N. Fungal infections in the recipients of solid organ transplantation. Infect Dis Clin North Am 2003;17:113-134.
7. Marr KA, Seidel K, Slavin MA, Bowden RA, Schoch HG, Flowers ME, et al. Prolonged fluconazole prophylaxis is associated with persistent protection against candidiasis-related death in allogenic marrow transplant recipients: long term follow-up of a randomized, placebo-controlled trial. Blood 2000;96:2055-2061.
8. Winston DJ, Pakrasi A, Busuttil RW. Prophylactic fluconazole in liver transplant recipient. A randomized double blind controlled trial. Ann Intern Med 1999;131:729-737.
9. Gamis AS, Gudnason T, Giebink GS, Ramsay NK, Disseminated infection with Fusarium in recipients of bone marrow transplants. Rev Infect Dis 1991;13:1077-1088.
10. Mowbray DN, Paller AS, Nelson PE, Kaplan RL. Disseminated Fusarium solani infection with cutaneous nodules in a bone marrow transplant patient. Int J Dermatol 1988; 27:698-701.
11. Bushelman SJ, Callen JP, Roth DN, Cohen LM. Disseminated Fusarium solani infection. J Am Acad Dermatol 1995;32(2 Pt 2):346-351.
12. Hennequin C, Lavarde V, Poirot JL, Rabodonirina M, Datry A, Aractingi S, et al. Invasive Fusarium infections: a retrospective survey of 31 cases. French Group d'Etude de Mycoses Opportunistes GEMO. J Med Vet Mycol 1997;35: 107.
13. Krcmery V Jr, Jesenska Z, Spanik S, Gyarfas J, Nogova J, Botek R, et al. Fungaemia due to Fusarium spp in cancer patients. J Hosp Infect 1997;35:107-114.
14. Pujol I, Guarro J, Gene J, Sala J. In vitro antifungal susceptibility of clinical and environmental Fusarium spp. Strains. J Antimicrob Chemother 1997;39:163-167.
15. Speeleveld E, Gordts B, Van Landuyt HW, De Vroey C, Raes-Wuytack C. Susceptibility of clinical isolates of Fusarium to antifungal drugs. Mycoses 1996;39:37-40.
16. Boucher HW, Groll AH, Chtou CC, Walsh TJ. Newer systemic antifungal agents: pharmacokinetics, safety and efficacy. Drugs 2004;64:1997-2020.
17. Consigny S, Dhedin N, Datry A, Choquet S, Leblond V, Chosidow O. Successful voriconazole treatment of disseminated Fusarium infection in an immunocompromised patient. Clin Infect Dis 2003;37:311-313.
18. Garbino J, Uckay I, Rohner P, Lew D, Van Delden C. Fusarium peritonitis concomitant to kidney transplantation successfully managed with voriconazole: case report and review of the literature. Transpl Int 2005;18:613-618.
19. Perfect JR, Marr KA, Walsh TJ, Greenberg RN, DuPont B, de la Torre-Cisneros J, et al. Voriconazole treatment for less-common, emerging, or refractory fungal infections. Clin Infect Dis 2003;36:1122-1131.
20. Guzman-Cottrill JA, Zheng X, Chadwick EG. Fusarium solant endocarditis successfully treated with liposomal amphotericin B and voriconazole. Pediatr Infect Dis J 2004;23:1059-1061.
21. Raad II, Hachem RY, Herbrecht R, Graybill JR, Hare R, Corcoran G, et al. Posaconazole as salvage treatment for invasive fusariosis in patients with underlying hematologic malignancies and other conditions. Clin Infect Dis 2006;42:1398-1403.
22. Dannaoui E, Meletiadis J, Mouton JW, Meis JF, Verweij PE; Eurofung Network. In vitro susceptibilities of zygomycetes to conventional and new antifungals. J Antimicrob Chemother 2003;51:45-52.
23. Guzman-Cottrill JA, Zheng X, Chadwick EG. Fusarium solant endocarditis successfully treated with liposomal amphotericin B and voriconazole. Pediatr Infect Dis J 2004;23:1059-1061.
24. Durand-Joly I, Alfandari S, Benchikh Z, Rodrigue M, Espinel-Ingroff A, Catteau B. Successful outcome of disseminated Fusarium infection with skin localization treated with voriconazole and amphotericin B-lipid complex in a patient with acute leukemia. J Clin Microbiol 2003;41: 4898-4900.
25. Young CN, Meyers AM. Opportunistic fungal infection by Fusarium oxysporum in a renal transplant patient. Sabouraudia 1979;17:219-223.
26. Heinz T, Perfect J, Schell W, Ritter E, Ruff G, Serafin D. Soft-tissue fungal infection: surgical management of 12 immunocompromised patients. Plast Reconstr Surg 1996; 97:1391-1399.
27. Sampathkumar P, Paya CV. Fusarium infection after solid organ transplantation. Clin Infect Dis 2001;32:1237-1240.
28. Girardi M, Glusac EJ, Imaeda S. Subcutaneous Fusarium foot abscess in a renal transplant patient. Cutis 1999;63: 267-270.
29. Cocuroccia B, Gaido J, Gubinelli E, Annessi G, Girolomoni G. Localized cutaneous hyalohyphomycosis caused by a Fusarium species infection in a renal patient. J Clin Microbiol 2003;41:90590-90597.
30. Guinvarc'h A, Guilbert L, Marmorat-Khuong A, Lavarde V, Chevalier P, Amrein C, et al. Disseminated Fusarium solani infection with endocarditis in a lung transplant recipient. Mycoses 1998;41:59-61.
31. Arney KL, Tiernan R, Judson MA. Primary pulmonary involvement of Fusarium solani in a lung transplant recipient. Chest 1997;112:1128-1130.